Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist.

@article{Muir1999HemodynamicAC,
  title={Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist.},
  author={Douglas Findlay Muir and Gerry P McCann and Lorna Swan and Andy Clark and William S. Hillis},
  journal={Clinical pharmacology and therapeutics},
  year={1999},
  volume={66 1},
  pages={85-90}
}
OBJECTIVE To investigate the systemic, pulmonary, and coronary artery effects of eletriptan, a new 5HT1B/1D-agonist in patients undergoing cardiac catheterization. METHODS Ten patients (two men and eight women) without significant obstructive coronary artery disease were administered 3.33 microg/kg/min intravenous eletriptan after they were given a placebo infusion of 0.9% saline solution. Serial measurements of right heart and systemic pressures were taken at 5-minute intervals during… CONTINUE READING
7 Citations
0 References
Similar Papers